Severity and Remission of Metabolic Dysfunction-Associated Fatty/Steatotic Liver Disease With Chronic Kidney Disease Occurrence.

Jingli GaoYuhao LiYijun ZhangXin ZhanXue TianJunjuan Li Ru Wang Yan He Anxin Wang Shouling Wu

Published in: Journal of the American Heart Association (2024)

The risk of CKD in patients with MAFLD/MASLD increased with the severity of hepatic steatosis. Even after remission of the disease, patients with MAFLD/MASLD with prior moderate to severe hepatic steatosis still had a higher risk of CKD.

Keyphrases

chronic kidney disease
end stage renal disease
disease activity
ulcerative colitis
risk assessment
oxidative stress
early onset